Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 25;217(6):887–896. doi: 10.1093/infdis/jix606

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 3. — Histopathological findings in mice infected with mouse-adapted CA04 virus and treated with laninamivir octanoate (LAO) + high-dose favipiravir (FA30) for 5 or 28 days. Lung histopathology in mice infected with mouse-adapted CA04 and treated with LAO and FA30 for 28 days (A and B) or for 5 days (C and D). Shown are hematoxylin and eosin staining (A and C) and immunostaining against influenza virus nucleoprotein (NP) antigen (B and D) on day 28 postinfection. Scale bars: 500 µm (A and C); 200 µm (B and D).